Plasminogen activator and pharmaceutical composition having thrombolytic activity
US4752603A · kind A · utility
24Cited by
5References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 28, 1986 |
| Grant date | Jun 21, 1988 |
| Priority date | — |
| Expiry date | May 28, 2006 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/828
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A new plasminogen activator which is very similar to the plasminogen activator from blood can be isolated in good amounts from the culture fluid of human melanoma cells. This new plasminogen activator has a strong thrombolytic effect and pharmaceutical compositions thereof may be used in the therapeutic treatment of thrombosis disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.